Kilitch Drugs (India) (NSE:KILITCH) Buildings And Improvements : ₹0 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Kilitch Drugs (India) Buildings And Improvements?

Kilitch Drugs (India)'s quarterly buildings and improvements declined from Mar. 2024 (₹40 Mil) to Jun. 2024 (₹0 Mil) but then stayed the same from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil).

Kilitch Drugs (India)'s annual buildings and improvements increased from Mar. 2022 (₹39 Mil) to Mar. 2023 (₹40 Mil) but then stayed the same from Mar. 2023 (₹40 Mil) to Mar. 2024 (₹40 Mil).

Kilitch Drugs (India) Buildings And Improvements Historical Data

The historical data trend for Kilitch Drugs (India)'s Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Buildings And Improvements Chart

Kilitch Drugs (India) Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Buildings And Improvements

Get a 7-Day Free Trial

39.43

40.02

Kilitch Drugs (India) Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Buildings And Improvements	Get a 7-Day Free Trial															-	-	40.02	-	-

Kilitch Drugs (India) Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Kilitch Drugs (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Buildings And Improvements

Traded in Other Exchanges

524500:India

Address

Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088

Website

https://www.kilitch.com

Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines